Clinical Excellence Research Center
The first university-based research center exclusively dedicated to discovering, testing, and evaluating cost-saving innovations in clinically excellent care. Our research seeks more affordable ways to deliver better care for conditions consuming the bulk of the country's healthcare spending.
CERC's Response to COVID-19
The Covid-19 crisis is challenging CERC’s faculty, scholars, and fellows to rapidly develop innovations that lower the cost of clinically excellent infectious disease care. Additionally, our Partnership in AI-Assisted Care, with faculty and graduate students from the computer science department, is moving ahead with computer vision applications to ease the burden on clinicians striving to deliver exceptional COVID care to ICU patients.
A Message From The Director
"Federal creditworthiness and therefore American prosperity now hinge on continuously attaining better health with less health spending. By rapidly mobilizing emerging science and technology from engineering, management, and medicine, the Clinical Excellence Research Center will enable Stanford to help solve a seemingly intractable national challenge."
- Arnold Milstein, MD, MPH
Dr. Milstein founded CERC after two decades of improving healthcare value in the private sector and advising the White House and Congress. He is now training America's next generation of healthcare innovators to remove wasteful and dangerous inefficiencies that ail the U.S. health-care system.
CERC NEWS & PUBLICATIONS
MedPage Today, May 15, 2020
Multiple factors at play: testing capacity, case definitions, age distribution, preparedness
MedPage Today May 12, 2020
Public health has taken a back seat to clinical diagnosis for too long
NEJM Catalyst, May 11, 2020
Health care organizations can benefit from decades of cross-industry research
INFORMS Journal on Applied Analytics, May 5, 2020
Healthcare lags decades behind other industries in operational analytics.
AMJ, June 2020
Applying India’s lessons would require substantial changes.
HMPI, May 2020
Providers need to rebuild consumer trust in a post-COVID world.
The Hill, May 7, 2020
The FDA has tightened their standards for antibody tests to identify people exposed to the coronavirus